Proteomic analysis of brain protein expression levels in NF-κβ p50 -/- homozygous knockout mice

Brain Research

Volumn 1240, Issue , 2008, Pages 22-30

  Owen, Joshua B ^a   Opii, Wycliffe O ^a   Ramassamy, Charles ^b,c   Pierce, William M ^d   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

NF kappa B; Oxidative stress; p50 knockout mice; Proteomics

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ATP SYNTHASE GAMMA; BRAIN PROTEIN; CARBONYL DERIVATIVE; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE C; HEAT SHOCK PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; FRONTAL CORTEX; HOMOZYGOTE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; WILD TYPE;

ALDEHYDES; ANIMALS; BRAIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; OXIDATIVE STRESS; PROTEOMICS; TYROSINE;

MUS;

EID: 54549095701     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.09.001     Document Type: Article

References (62)

1. Albensi B.C., and Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35 (2000) 151-159
2. Aleyasin H., Cregan S.P., Iyirhiaro G., O'Hare M.J., Callaghan S.M., Slack R.S., and Park D.S. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J. Neurosci 24 (2004) 2963-2973
3. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol 12 (1994) 141-179
4. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
5. Beg A.A., and Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274 (1996) 782-784
6. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 (1995) 167-170
7. Biswas G., Anandatheerthavarada H., Zaidi M., and Avadhini N. Mitochondria to nucleus stress signaling: a distinctive mechanism of NFκB/Rel activation through calcineurin-mediated inactivation of IκBβ. J. Cell. Biol 161 (2003) 507-519
8. Butterfield D.A. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 1000 (2004) 1-7
9. Butterfield D.A., and Stadtman E.R. Protein oxidation processes in aging brain. Adv. Cell. Aging Gerontol. 2 (1997) 161-191
10. Butterfield D.A., and Castegna A. Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids 25 (2003) 419-425
11. Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., and Butterfield D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85 (2003) 1394-1401
12. Chung, H.Y., Jung, K.J., Yu, B.P., 2005. Molecular inflammation as an underlying mechanism of aging: the anti-inflammatory action of calorie restriction. Oxidative stress, Inflammation and Health, Marcel Dekker, NY:387-419.
13. Culmsee C., Siewe J., Junker V., Retiounskaia M., Schwarz S., Camandola S., El-Metainy S., Behnke H., Mattson M.P., and Krieglstein J. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23 (2003) 8586-8595
14. Donninger H., Bonome T., Radonovich M., Pise-Masison C.A., Brady J., Shih J.H., Barrett J.C., and Birrer M.J. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene. 23 (2004) 8065-8077
15. Drake J., Sultana R., Aksenova M., Calabrese V., and Butterfield D.A. Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J. Neurosci. Res 74 (2003) 917-927
16. Fakhrzadeh L., Laskin J.D., and Laskin D.L. Ozone-induced production of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L279-285
17. Farr S.A., Poon H.F., Dogrukol-Ak D., Drake J., Banks W.A., Eyerman E., Butterfield D.A., and Morley J.E. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem. 84 (2003) 1173-1183
18. Ferrucci L., Ble A., Bandinelli S., Lauretani F., Suthers K., and Guralnik J.M. A flame burning within. Aging Clin. Exp. Res. 16 (2004) 240-243
19. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., and Packer L. Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22 (1997) 1115-1126
20. Gadjeva M., Tomczak M.F., Zhang M., Wang Y.Y., Dull K., Rogers A.B., Erdman S.E., Fox J.G., Carroll M., and Horwitz B.H. A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J. Immunol. 173 (2004) 5786-5793
21. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
22. Grilli M., Chiu J.J., and Lenardo M.J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143 (1993) 1-62
23. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes. Dev. 18 (2004) 2195-2224
24. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Schoonhoven R., Grisham J.W., and Brenner D.A. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101 (1998) 802-811
25. Je J.H., Lee J.Y., Jung K.J., Sung B., Go E.K., Yu B.P., and Chung H.Y. NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Lett. 566 (2004) 183-189
26. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., and Baeuerle P.A. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14 (1994) 3981-3992
27. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
28. Kassed C.A., and Herkenham M. NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety. Behav. Brain Res. 154 (2004) 577-584
29. Kassed C.A., Willing A.E., Garbuzova-Davis S., Sanberg P.R., and Pennypacker K.R. Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp. Neurol. 176 (2002) 277-288
30. Kato A., Edwards M.J., and Lentsch A.B. Gene deletion of NF-kappa B p50 does not alter the hepatic inflammatory response to ischemia/reperfusion. J. Hepatol. 37 (2002) 48-55
31. Kim H.J., Kim K.W., Yu B.P., and Chung H.Y. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic. Biol. Med. 28 (2000) 683-692
32. Laskin D.L., and Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 655-677
33. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., and Butterfield D.A. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 78 (2001) 413-416
34. Leyva J.A., Bianchet M.A., and Amzel L.M. Understanding ATP synthesis: structure and mechanism of the F1-ATPase (Review). Mol. Membr. Biol. 20 (2003) 27-33
35. Lipton S.A. Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat. Med. 3 (1997) 20-22
36. Lu Z.Y., Yu S.P., Wei J.F., and Wei L. Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience 139 (2006) 965-978
37. Mabley J.G., Hasko G., Liaudet L., Soriano F., Southan G.J., Salzman A.L., and Szabo C. NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J. Endocrinol. 173 (2002) 457-464
38. Mattson M.P., Culmsee C., Yu Z., and Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74 (2000) 443-456
39. May M.J., and Ghosh S. Signal transduction through NF-kappa B. Immunol. Today 19 (1998) 80-88
40. Messina S., Altavilla D., Aguennouz M., Seminara P., Minutoli L., Monici M.C., Bitto A., Mazzeo A., Marini H., Squadrito F., and Vita G. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol. 168 (2006) 918-926
41. Moorthy A.K., Savinova O.V., Ho J.Q., Wang V.Y., Vu D., and Ghosh G. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. Embo. J. 25 (2006) 1945-1956
42. Motohashi H., and Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10 (2004) 549-557
43. Mulkidjanian A.Y. Ubiquinol oxidation in the cytochrome bc1 complex: reaction mechanism and prevention of short-circuiting. Biochim. Biophys. Acta. 1709 (2005) 5-34
44. Nishihara J.C., and Champion K.M. Quantitative evaluation of proteins in one- and two-dimensional polyacrylamide gels using a fluorescent stain. Electrophoresis 23 (2002) 2203-2215
45. Nurmi A., Lindsberg P.J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M.L., Weih F., Frank N., Schwaninger M., and Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 (2004) 987-991
46. O'Donnell S.M., Hansberger M.W., Connolly J.L., Chappell J.D., Watson M.J., Pierce J.M., Wetzel J.D., Han W., Barton E.S., Forrest J.C., Valyi-Nagy T., Yull F.E., Blackwell T.S., Rottman J.N., Sherry B., and Dermody T.S. Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J. Clin. Invest. 115 (2005) 2341-2350
47. O'Neill L.A., and Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20 (1997) 252-258
48. Pennypacker K.R., Kassed C.A., Eidizadeh S., Saporta S., Sanberg P.R., and Willing A.E. NF-kappaB p50 is increased in neurons surviving hippocampal injury. Exp. Neurol. 172 (2001) 307-319
49. Perham R.N. The fructose-1,6-bisphosphate aldolases: same reaction, different enzymes. Biochem. Soc. Trans. 18 (1990) 185-187
50. Poon H.F., Calabrese V., Scapagnini G., and Butterfield D.A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J. Gerontol. A. Biol. Sci. Med. Sci. 59 (2004) 478-493
51. Poon H.F., Joshi G., Sultana R., Farr S.A., Banks W.A., Morley J.E., Calabrese V., and Butterfield D.A. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res. 1018 (2004) 86-96
52. Santoro M.G., Rossi A., and Amici C. NF-kappaB and virus infection: who controls whom. Embo. J. 22 (2003) 2552-2560
53. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5 (1999) 554-559
54. Sha W.C., Liou H.C., Tuomanen E.I., and Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune response. Cell 80 (1995) 321-330
55. Sun Z., and Andersson R. NF-kappaB activation and inhibition: a review. Shock 18 (2002) 99-106
56. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., and Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116 (2006) 984-995
57. Thongboonkerd V., McLeish K.R., Arthur J.M., and Klein J.B. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 62 (2002) 1461-1469
58. Weih F., Durham S.K., Barton D.S., Sha W.C., Baltimore D., and Bravo R. p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J. Exp. Med. 185 (1997) 1359-1370
59. Weiss H., Friedrich T., Hofhaus G., and Preis D. The respiratory-chain NADH dehydrogenase (complex I) of mitochondria. Eur. J. Biochem. 197 (1991) 563-576
60. Yang H., Magilnick N., Lee C., Kalmaz D., Ou X., Chan J.Y., and Lu S.C. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol. Cell. Biol. 25 (2005) 5933-5946
61. Yu Z., Zhou D., Bruce-Keller A.J., Kindy M.S., and Mattson M.P. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19 (1999) 8856-8865
62. Yu Z., Cheng G., Wen X., Wu G.D., Lee W.T., and Pleasure D. Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappaB-dependent mechanism. Neurobiol. Dis. 11 (2002) 199-213